JonFleetwood.com
Jon FleetwoodIndependent, document-driven investigative reporting focused on health policy, biotechnology, biosecurity, and government decision-making.
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 799 | Subscribers | Read | jonfleetwood.substack.com |
Curious about how many subscribers JonFleetwood.com has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Illinois Bill Turns Hospitals Into Mass Influenza Shot Intake Points for Every Adult, Mandates Universal Identification and Targeting System
A newly introduced Illinois bill would require hospitals across the state to systematically identify and offer influenza vaccines to every adult patient, embedding flu shot targeting into standard hospital operations.
WHO Influenza Plan Orchestrates Global mRNA-Based 'Next-Generation' Pandemic Vaccine System Through 2050—46 Vaccines Already Underway
World Health Organization (WHO) press release from last month is drawing attention to the powerful foreign body’s push for next-generation influenza vaccines, stating they “could play a vital role in reducing the global burden of influenza”...
MenB Vaccine Aluminum Doses Overlap Equivalent mg/kg Levels That Produced Motor Neuron Death, Brain Inflammation, and Neurodegenerative Brain Changes in Peer-Reviewed Mammalian Study
As Meningitis B vaccines are being pushed in the U.K. in response to a reported outbreak, the U.S. Food and Drug Administration (FDA) product insert confirms that each 0.5 mL dose of the meningococcal Group B vaccine Bexsero contains 1.5 mg...
Meningitis B Vaccine Contains Chimeric Bioengineered Bacterial Proteins and Aluminum—96% Adverse Reaction Rate, 29% Experience Severe Reaction
The meningococcal B (MenB) vaccine BEXSERO contains bioengineered bacterial proteins—including chimeric (“Frankenstein”) antigens—and aluminum, while FDA regulatory documents and clinical trial data show that up to 96% of recipients experie...
Authors
The writers behind this newsletter.
Frequently Asked Questions
How can I access the email archive for JonFleetwood.com?
You can find recent issues that have been published by JonFleetwood.com on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does JonFleetwood.com have?
To see how many people subscribe to JonFleetwood.com, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in JonFleetwood.com?
Newsletter advertising can be extremely effective when it's done right. Before you pitch JonFleetwood.com as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like JonFleetwood.com?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact JonFleetwood.com using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to JonFleetwood.com?
Scroll up to where it says Similar Newsletters to see other publications like JonFleetwood.com. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact JonFleetwood.com?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.